Quam Health & Entertainment Flexible Allocation Hybrid Securities Investment Fund (abbreviation: Quam Health & Entertainment Flexible Allocation Hybrid C, code 019200) announced its latest net value on November 1, down 3.14%.
Quam Health & Entertainment Flexible Allocation Hybrid C was established on September 1, 2023, and the performance comparison benchmark is the yield of the CSI 300 Index ×50% + the yield of the SSE Treasury Bond Index ×50%. The fund has returned -8.97% since its inception, -21.35% this year, -8.60% over the past month, and -20.10% over the past year. In the past year, the fund ranked 7490/7617 in its peer group.
The fund manager is Liao Qingyang. Liao Qingyang has managed (or intends to manage) the fund since September 1, 2023, with a return of -8.97% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 688235 | BeiGene | 5.72% | 100000 | 18.046 million |
| 688319 | Olin Biotech | 4.05% | 1200000 | 12.768 million |
| 300015 | Aier Ophthalmology | 4.04% | 800000 | 12.728 million |
| 688301 | Yirui Technology | 4.02% | 100000 | 12.684 million |
| 301239 | Purui Ophthalmology | 3.80% | 260000 | 11.9756 million |
| 002755 | Aosaikang | 3.77% | 1000000 | 11.88 million |
| 300957 | Bethany | 3.56% | 180000 | 11.2356 million |
| 000661 | Changchun High-tech | 3.49% | 100000 | 10.989 million |
| 300573 | Xingqi eye medicine | 3.40% | 100000 | 10.716 million |
| 300896 | Aimeike | 3.36% | 45000 | 10.602 million |
Ticker Name
Percentage Change
Inclusion Date
